title: [A case of complete response (CR) persisting for 2 years from S-1 administered five days a week in a patient with gastric cancer].
abstract: We attempted S-1 administered five days a week from March, 2004 for an 84-year-old female harboring Borrmann type 1 gastric cancer because her family did not agree to her gastrectomy. After treatment for 1 month the lesion changed into a shallow ulcer. The lesion was clinically diagnosed with CR about 3 months later. As of October, 2006, 2 years after inducing CR, we have been administering S-1 to the patient, with no regrowth of the tumor.
authors.affiliation: Dept. of Surgery, Omihachiman Community Medical Center.
authors.forename: Kuniyuki
authors.initials: K
authors.lastname: Tsuchiya
authors.forename: Hisayuki
authors.initials: H
authors.lastname: Miyagi
authors.forename: Kaori
authors.initials: K
authors.lastname: Okugawa
authors.forename: Kenji
authors.initials: K
authors.lastname: Nakamura
authors.forename: Katsunori
authors.initials: K
authors.lastname: Nakano
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Osaka
authors.forename: Shigeru
authors.initials: S
authors.lastname: Takahashi
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Sako
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006801:Humans; D010094:Oxonic Acid / Q000627:therapeutic use*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005641:Tegafur / Q000627:therapeutic use*
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid